PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

EORTC presents European solution for effective cancer drug development

2014-07-01
(Press-News.org) Drug developers are facing the perfect storm. They are confronted with major patent expiries, increased payer scrutiny, changing priorities, shifting business models, increased risk averseness, increased clinical trial costs, not to mention issues concerning R&D productivity. There needs to be a better way to identify new candidate drugs. There needs to be a new drug development pathway that is compatible with research aimed at understanding the biology of a cancer and simultaneously able to support the design and conduct of subsequent confirmatory trials, but building and maintaining such a drug development pathway is beyond the ability of individual organizations or companies. It has been argued that new forms of partnership as well as an integrated model of cancer research are needed. Now, in a paper published in Nature Reviews Clinical Oncology, the EORTC describes how collaborative molecular screening platforms could help serve these needs.

Collaborative molecular screening platforms offer a high quality integrated infrastructure for efficient screening of patients with cancer for specific molecular alterations. These identified alterations will define target populations for early trials with novel targeted agents. Pharmaceutical industry partners would be in a position to propose candidate drugs for clinical trials which could be plugged into the platform. Patients fulfilling the inclusion criteria for one or more trials would be notified by their physician and given the option of participating.

Dr. Denis Lacombe, EORTC Director and lead author of this paper says, "Collaborative molecular screening platforms will offer patients efficient access to new therapeutic agents. Clinical research will be turned on its head. Instead of designing trials which must find patients for a particular drug, the question will become which drug should be given to a particular subset of patients with an identified molecular alteration."

Collaborative molecular screening platforms are a winning proposition for all cancer drug development stakeholders. As information-sharing platforms they enable us to learn from our failures. They accommodate the integration of information from continuous risk assessments and pave the way for an adaptive licensing strategy. Importantly, they enhance the expertise of the constituent partners by combining their efforts within a cost-sharing model and could very well be the realization of personalized medicine. INFORMATION:


ELSE PRESS RELEASES FROM THIS DATE:

Unsuspected aspect of immune regulation revealed

2014-07-01
A discovery by Australian immunologists, uncovering an additional role for antibody-making 'B cells', is considered important enough by the American Association of Immunologists to rank it among the top 10% of articles in the latest issue of The Journal of Immunology, off the press today. The finding by Senior Research Assistant Stacey Walters and Associate Professor Shane Grey, from Sydney's Garvan Institute of Medical Research, shows that B cells also participate in the development of 'regulatory T cells'. T cells develop in the thymus gland, a soft triangular organ ...

New analysis of 'swine flu' pandemic conflicts with accepted views on how diseases spread

New analysis of swine flu pandemic conflicts with accepted views on how diseases spread
2014-07-01
The most detailed analysis to date of the spread of the H1N1 2009 pandemic influenza virus, known informally as 'swine flu', has found that short-range travel was likely the primary driver for the 2009 pandemic in the United States, in contrast with popularly accepted views on the way diseases spread. The study, based on data gathered from health insurance claims made throughout 2009, found that international air travel, which was previously thought to be important in the pandemic, played only a minor role in its spread within the US. A team of researchers from University ...

Cancer risk: Aspirin and smoking affect aging of genes

Cancer risk: Aspirin and smoking affect aging of genes
2014-07-01
The risk of developing cancer increases with age. Factors like smoking and regular aspirin use also affect the risk of cancer – although in the opposite sense. Researchers from the University of Basel were now able to show that aspirin use and smoking both influence aging processes of the female genome that are connected to colorectal cancer. The Journal of the National Cancer Institute has published their results. Already in the 1990s, scientists discovered that regular use of aspirin over long periods of time decreases the cancer risk. Since then, numerous studies have ...

Analysis of the Chinese facial profile: Contours of the side face in the Tu & Zang ethnic minorities

2014-07-01
Li Haijun and fellow researchers at Minzu University of China, in Beijing, conducted a series of geometric morphometric analyses of the contours of the side face and variations in the Tu and Zang (Tibetan) ethnic minorities from Qinghai Province, in northwestern China. Their study, entitled "Morphometric analysis of the Chinese facial profile: Contours of the side face and variations in the Tu and Zang ethnic minorities", was published (in Chinese) in the Chinese Science Bulletin, 2014, Vol 59(16). The team of researchers used advanced digital cameras and image processing ...

A Spaniard and a Portuguese discover a new species of beetle in the world's deepest cave

A Spaniard and a Portuguese discover a new species of beetle in the worlds deepest cave
2014-07-01
The unusual habitat of the Krubera cave in the Western Caucasus remains a mystery. Researchers from two Spanish universities have discovered a new species of beetle in the depths of this cave. Cave beetles are one of the most iconic species found in subterranean habitats. They were historically the first living organisms described by science that are adapted to the conditions of hypogean or subterranean life. Now, a Portuguese scientist and a Spaniard have discovered a new species of beetle in the deepest cave known to man; a cave 2,140 metres deep. It is the Krubera ...

Scientists uncover the key to adaptation limits of ocean dwellers

2014-07-01
The simpler, the more heat-resistant – scientists uncover the key to adaptation limits of ocean dwellers Bremerhaven, Germany, 1 July 2014. The simpler a marine organism is structured, the better it is suited for survival during climate change. Scientists of the Alfred Wegener Institute, Helmholtz Centre for Polar and Marine Research discovered this in a new meta-study, which appears today in the research journal Global Change Biology. For the first time biologists studied the relationship between the complexity of life forms and the ultimate limits of their adaptation ...

The biology of addiction risk looks like addiction

2014-07-01
Philadelphia, PA, July 1, 2014 – Research suggests that people at increased risk for developing addiction share many of the same neurobiological signatures of people who have already developed addiction. This similarity is to be expected, as individuals with family members who have struggled with addiction are over-represented in the population of addicted people. However, a generation of animal research supports the hypothesis that the addiction process changes the brain in ways that converge with the distinctive neurobiology of the heritable risk for addiction. In other ...

In study of individual neuron activity, key brain region responds to subjective perception

2014-07-01
LOS ANGELES (June 30, 2014) – When evaluating another person's emotions – happy, sad, angry, afraid – humans take cues from facial expressions. Neurons in a part of the brain called the amygdala "fire" in response to the visual stimulation as information is processed by the retina, the amygdala and a network of interconnected brain structures. Some of these regions respond just to the actual features of the face, whereas others respond to how things appear to the viewer, but it is unknown where in the brain this difference arises. Although the amygdala's importance in ...

Up in flames: Evidence confirms combustion theory

Up in flames: Evidence confirms combustion theory
2014-07-01
Researchers at the Department of Energy's Lawrence Berkeley National Lab (Berkeley Lab) and the University of Hawaii have uncovered the first step in the process that transforms gas-phase molecules into solid particles like soot and other carbon-based compounds. The finding could help combustion chemists make more-efficient, less-polluting fuels and help materials scientists fine-tune their carbon nanotubes and graphene sheets for faster, smaller electronics. In addition, the results could have implications for the burgeoning field of astrochemistry, potentially establishing ...

Study finds online bullying creates off-line fear at school

Study finds online bullying creates off-line fear at school
2014-07-01
HUNTSVILLE, TX (7/1/14) -- Cyberbullying creates fear among students about being victimized at school, a recent study by Sam Houston State University found. While traditional bullying still creates the most fear among students, cyberbullying is a significant factor for fear of victimization at school among students who have experienced bullying or disorder At school, such as the presence of gangs. The fear from cyberbullying is most prominent in minority populations. "It cannot be overstated – online victimization has offline consequences, and those consequences may ...

LAST 30 PRESS RELEASES:

For solar power to truly provide affordable energy access, we need to deploy it better

Middle-aged men are most vulnerable to faster aging due to ‘forever chemicals’

Starving cancer: Nutrient deprivation effects on synovial sarcoma

Speaking from the heart: Study identifies key concerns of parenting with an early-onset cardiovascular condition

From the Late Bronze Age to today - Old Irish Goat carries 3,000 years of Irish history

Emerging class of antibiotics to tackle global tuberculosis crisis

Researchers create distortion-resistant energy materials to improve lithium-ion batteries

Scientists create the most detailed molecular map to date of the developing Down syndrome brain

Nutrient uptake gets to the root of roots

Aspirin not a quick fix for preventing bowel cancer

HPV vaccination provides “sustained protection” against cervical cancer

Many post-authorization studies fail to comply with public disclosure rules

GLP-1 drugs combined with healthy lifestyle habits linked with reduced cardiovascular risk among diabetes patients

Solved: New analysis of Apollo Moon samples finally settles debate about lunar magnetic field

University of Birmingham to host national computing center 

Play nicely: Children who are not friends connect better through play when given a goal

Surviving the extreme temperatures of the climate crisis calls for a revolution in home and building design

The wild can be ‘death trap’ for rescued animals

New research: Nighttime road traffic noise stresses the heart and blood vessels  

Meningococcal B vaccination does not reduce gonorrhoea, trial results show

AAO-HNSF awarded grant to advance age-friendly care in otolaryngology through national initiative

Eight years running: Newsweek names Mayo Clinic ‘World’s Best Hospital’

Coffee waste turned into clean air solution: researchers develop sustainable catalyst to remove toxic hydrogen sulfide

Scientists uncover how engineered biochar and microbes work together to boost plant-based cleanup of cadmium-polluted soils

Engineered biochar could unlock more effective and scalable solutions for soil and water pollution

Differing immune responses in infants may explain increased severity of RSV over SARS-CoV-2

The invisible hand of climate change: How extreme heat dictates who is born

Surprising culprit leads to chronic rejection of transplanted lungs, hearts

Study explains how ketogenic diets prevent seizures

New approach to qualifying nuclear reactor components rolling out this year

[Press-News.org] EORTC presents European solution for effective cancer drug development